US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 123.370
  • +1.470+1.21%
Close Dec 26 16:00 ET
  • 123.370
  • 0.0000.00%
Pre 08:06 ET
11.78BMarket Cap80.11P/E (TTM)

Sarepta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
40.79%467.17M
38.93%362.93M
63.10%413.46M
33.26%1.24B
53.54%396.78M
44.10%331.82M
11.89%261.24M
20.24%253.5M
32.93%933.01M
28.28%258.43M
Operating revenue
40.79%467.17M
38.93%362.93M
63.10%413.46M
33.26%1.24B
53.54%396.78M
44.10%331.82M
11.89%261.24M
20.24%253.5M
32.93%933.01M
28.28%258.43M
Cost of revenue
147.64%91.69M
30.54%44.55M
44.38%50.56M
7.40%150.34M
43.43%44.18M
-7.32%37.03M
-9.71%34.12M
11.37%35.02M
44.25%139.99M
-2.98%30.8M
Gross profit
27.37%375.48M
40.19%318.39M
66.10%362.91M
37.83%1.09B
54.90%352.61M
54.89%294.79M
16.06%227.11M
21.79%218.48M
31.11%793.02M
34.12%227.63M
Operating expense
11.93%353.29M
-11.52%319.09M
-8.01%328M
2.38%1.36B
-1.94%327.98M
-1.88%315.63M
-11.35%360.63M
33.91%356.57M
26.05%1.33B
21.39%334.46M
Selling and administrative expenses
6.04%128.2M
17.06%138.8M
14.71%127M
6.75%481.87M
9.31%131.7M
15.37%120.89M
-23.17%118.56M
54.11%110.71M
59.70%451.42M
54.35%120.48M
-General and administrative expense
6.04%128.2M
17.06%138.8M
14.71%127M
6.75%481.87M
9.31%131.7M
15.37%120.89M
-23.17%118.56M
54.11%110.71M
--451.42M
--120.48M
Research and development costs
15.53%224.48M
-25.71%179.69M
-18.43%200.4M
0.03%877.39M
-8.55%195.52M
-10.34%194.3M
-4.14%241.89M
26.48%245.68M
13.73%877.09M
8.37%213.8M
Depreciation amortization depletion
37.13%602K
235.75%601K
237.64%601K
118.35%1.56M
326.26%763K
146.63%439K
0.00%179K
0.00%178K
1.13%714K
0.00%179K
-Depreciation and amortization
37.13%602K
235.75%601K
237.64%601K
118.35%1.56M
326.26%763K
146.63%439K
0.00%179K
0.00%178K
1.13%714K
0.00%179K
Operating profit
206.50%22.2M
99.47%-701K
125.28%34.91M
50.05%-267.82M
123.05%24.63M
84.13%-20.84M
36.76%-133.52M
-58.94%-138.09M
-19.23%-536.2M
-0.96%-106.83M
Net non-operating interest income expense
-23.75%13.42M
-12.33%14.01M
21.08%15.73M
350.57%63.96M
96.21%17.39M
369.79%17.59M
217.34%15.98M
183.38%12.99M
59.49%-25.53M
156.12%8.87M
Non-operating interest income
-19.67%18.33M
-11.14%18.84M
3.01%19.9M
210.10%85.97M
45.49%22.63M
177.81%22.82M
780.20%21.2M
8,883.72%19.32M
5,325.24%27.72M
6,071.83%15.55M
Non-operating interest expense
-5.95%4.92M
-7.50%4.83M
-34.11%4.17M
-58.67%22.01M
-21.74%5.23M
-64.52%5.23M
-67.41%5.22M
-59.97%6.32M
-16.18%53.25M
-58.33%6.69M
Other net income (expense)
94.64%-1.61M
-99.74%268K
97.63%-9.19M
-146.60%-316.23M
50.63%-1.65M
74.76%-29.93M
3,180.61%102.95M
-22,917.46%-387.61M
-236.75%-128.24M
-1,092.14%-3.34M
Special income (charges)
105.20%1.54M
--0
97.39%-10.1M
-245.26%-418.85M
2.91%-2.5M
75.16%-29.5M
--800K
---387.33M
-1,564.60%-121.32M
---2.58M
-Less：Restructuring and merger&acquisition
-176.75%-1.54M
--0
--10.1M
117.91%1.2M
--0
129.85%2M
---800K
--0
6.94%-6.7M
--0
-Less:Other special charges
----
----
----
208.77%387.33M
--0
----
----
--387.33M
1,154.41%125.44M
--0
-Write off
--0
----
----
1,077.51%30.32M
-2.91%2.5M
--27.5M
----
----
-42.62%2.58M
--2.58M
Other non- operating income (expenses)
-638.82%-3.14M
-99.74%268K
420.00%912K
1,582.69%102.62M
211.66%852K
-313.57%-425K
2,286.05%102.15M
83.08%-285K
-106.85%-6.92M
-172.50%-763K
Income before tax
202.51%34.01M
193.09%13.58M
108.08%41.45M
24.62%-520.1M
139.85%40.37M
87.06%-33.17M
93.61%-14.59M
-392.30%-512.71M
-64.69%-689.96M
16.89%-101.31M
Income tax
-94.91%395K
-23.92%7.12M
31.74%5.33M
17.40%15.88M
-166.57%-5.28M
488.11%7.76M
176.12%9.36M
360.18%4.05M
8,150.60%13.53M
8,528.26%7.94M
Net income
182.10%33.61M
126.98%6.46M
106.99%36.12M
23.81%-535.98M
141.79%45.66M
84.12%-40.94M
89.66%-23.94M
-392.03%-516.76M
-67.99%-703.49M
10.44%-109.24M
Net income continuous Operations
182.10%33.61M
126.98%6.46M
106.99%36.12M
23.81%-535.98M
141.79%45.66M
84.12%-40.94M
89.66%-23.94M
-392.03%-516.76M
-67.99%-703.49M
10.44%-109.24M
Minority interest income
Net income attributable to the parent company
182.10%33.61M
126.98%6.46M
106.99%36.12M
23.81%-535.98M
141.79%45.66M
84.12%-40.94M
89.66%-23.94M
-392.03%-516.76M
-67.99%-703.49M
10.44%-109.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
182.10%33.61M
126.98%6.46M
106.99%36.12M
23.81%-535.98M
141.79%45.66M
84.12%-40.94M
89.66%-23.94M
-392.03%-516.76M
-67.99%-703.49M
10.44%-109.24M
Basic earnings per share
176.09%0.35
125.93%0.07
106.48%0.38
27.77%-5.8
161.29%0.76
84.35%-0.46
89.81%-0.27
-388.33%-5.86
-55.92%-8.03
13.29%-1.24
Diluted earnings per share
173.91%0.34
125.93%0.07
106.31%0.37
27.77%-5.8
161.29%0.76
84.35%-0.46
89.81%-0.27
-388.33%-5.86
-55.92%-8.03
13.29%-1.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 40.79%467.17M38.93%362.93M63.10%413.46M33.26%1.24B53.54%396.78M44.10%331.82M11.89%261.24M20.24%253.5M32.93%933.01M28.28%258.43M
Operating revenue 40.79%467.17M38.93%362.93M63.10%413.46M33.26%1.24B53.54%396.78M44.10%331.82M11.89%261.24M20.24%253.5M32.93%933.01M28.28%258.43M
Cost of revenue 147.64%91.69M30.54%44.55M44.38%50.56M7.40%150.34M43.43%44.18M-7.32%37.03M-9.71%34.12M11.37%35.02M44.25%139.99M-2.98%30.8M
Gross profit 27.37%375.48M40.19%318.39M66.10%362.91M37.83%1.09B54.90%352.61M54.89%294.79M16.06%227.11M21.79%218.48M31.11%793.02M34.12%227.63M
Operating expense 11.93%353.29M-11.52%319.09M-8.01%328M2.38%1.36B-1.94%327.98M-1.88%315.63M-11.35%360.63M33.91%356.57M26.05%1.33B21.39%334.46M
Selling and administrative expenses 6.04%128.2M17.06%138.8M14.71%127M6.75%481.87M9.31%131.7M15.37%120.89M-23.17%118.56M54.11%110.71M59.70%451.42M54.35%120.48M
-General and administrative expense 6.04%128.2M17.06%138.8M14.71%127M6.75%481.87M9.31%131.7M15.37%120.89M-23.17%118.56M54.11%110.71M--451.42M--120.48M
Research and development costs 15.53%224.48M-25.71%179.69M-18.43%200.4M0.03%877.39M-8.55%195.52M-10.34%194.3M-4.14%241.89M26.48%245.68M13.73%877.09M8.37%213.8M
Depreciation amortization depletion 37.13%602K235.75%601K237.64%601K118.35%1.56M326.26%763K146.63%439K0.00%179K0.00%178K1.13%714K0.00%179K
-Depreciation and amortization 37.13%602K235.75%601K237.64%601K118.35%1.56M326.26%763K146.63%439K0.00%179K0.00%178K1.13%714K0.00%179K
Operating profit 206.50%22.2M99.47%-701K125.28%34.91M50.05%-267.82M123.05%24.63M84.13%-20.84M36.76%-133.52M-58.94%-138.09M-19.23%-536.2M-0.96%-106.83M
Net non-operating interest income expense -23.75%13.42M-12.33%14.01M21.08%15.73M350.57%63.96M96.21%17.39M369.79%17.59M217.34%15.98M183.38%12.99M59.49%-25.53M156.12%8.87M
Non-operating interest income -19.67%18.33M-11.14%18.84M3.01%19.9M210.10%85.97M45.49%22.63M177.81%22.82M780.20%21.2M8,883.72%19.32M5,325.24%27.72M6,071.83%15.55M
Non-operating interest expense -5.95%4.92M-7.50%4.83M-34.11%4.17M-58.67%22.01M-21.74%5.23M-64.52%5.23M-67.41%5.22M-59.97%6.32M-16.18%53.25M-58.33%6.69M
Other net income (expense) 94.64%-1.61M-99.74%268K97.63%-9.19M-146.60%-316.23M50.63%-1.65M74.76%-29.93M3,180.61%102.95M-22,917.46%-387.61M-236.75%-128.24M-1,092.14%-3.34M
Special income (charges) 105.20%1.54M--097.39%-10.1M-245.26%-418.85M2.91%-2.5M75.16%-29.5M--800K---387.33M-1,564.60%-121.32M---2.58M
-Less：Restructuring and merger&acquisition -176.75%-1.54M--0--10.1M117.91%1.2M--0129.85%2M---800K--06.94%-6.7M--0
-Less:Other special charges ------------208.77%387.33M--0----------387.33M1,154.41%125.44M--0
-Write off --0--------1,077.51%30.32M-2.91%2.5M--27.5M---------42.62%2.58M--2.58M
Other non- operating income (expenses) -638.82%-3.14M-99.74%268K420.00%912K1,582.69%102.62M211.66%852K-313.57%-425K2,286.05%102.15M83.08%-285K-106.85%-6.92M-172.50%-763K
Income before tax 202.51%34.01M193.09%13.58M108.08%41.45M24.62%-520.1M139.85%40.37M87.06%-33.17M93.61%-14.59M-392.30%-512.71M-64.69%-689.96M16.89%-101.31M
Income tax -94.91%395K-23.92%7.12M31.74%5.33M17.40%15.88M-166.57%-5.28M488.11%7.76M176.12%9.36M360.18%4.05M8,150.60%13.53M8,528.26%7.94M
Net income 182.10%33.61M126.98%6.46M106.99%36.12M23.81%-535.98M141.79%45.66M84.12%-40.94M89.66%-23.94M-392.03%-516.76M-67.99%-703.49M10.44%-109.24M
Net income continuous Operations 182.10%33.61M126.98%6.46M106.99%36.12M23.81%-535.98M141.79%45.66M84.12%-40.94M89.66%-23.94M-392.03%-516.76M-67.99%-703.49M10.44%-109.24M
Minority interest income
Net income attributable to the parent company 182.10%33.61M126.98%6.46M106.99%36.12M23.81%-535.98M141.79%45.66M84.12%-40.94M89.66%-23.94M-392.03%-516.76M-67.99%-703.49M10.44%-109.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 182.10%33.61M126.98%6.46M106.99%36.12M23.81%-535.98M141.79%45.66M84.12%-40.94M89.66%-23.94M-392.03%-516.76M-67.99%-703.49M10.44%-109.24M
Basic earnings per share 176.09%0.35125.93%0.07106.48%0.3827.77%-5.8161.29%0.7684.35%-0.4689.81%-0.27-388.33%-5.86-55.92%-8.0313.29%-1.24
Diluted earnings per share 173.91%0.34125.93%0.07106.31%0.3727.77%-5.8161.29%0.7684.35%-0.4689.81%-0.27-388.33%-5.86-55.92%-8.0313.29%-1.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
SilverCrest Metals
SILV
+2.40%
Cars.com
CARS
+2.25%
Lantheus
LNTH
+2.14%
Collegium Pharmaceutical
COLL
+1.48%
Hutchmed (China)
HCM
+1.19%

Unlock the Full List